WO2004060341A2 - Increasing skin cell renewal with water-soluble vitamin e - Google Patents
Increasing skin cell renewal with water-soluble vitamin e Download PDFInfo
- Publication number
- WO2004060341A2 WO2004060341A2 PCT/US2003/039275 US0339275W WO2004060341A2 WO 2004060341 A2 WO2004060341 A2 WO 2004060341A2 US 0339275 W US0339275 W US 0339275W WO 2004060341 A2 WO2004060341 A2 WO 2004060341A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- water
- skin
- vitamin
- soluble vitamin
- Prior art date
Links
- 230000001965 increasing effect Effects 0.000 title description 18
- 210000004927 skin cell Anatomy 0.000 title description 15
- 229940088594 vitamin Drugs 0.000 title description 3
- 229930003231 vitamin Natural products 0.000 title description 3
- 235000013343 vitamin Nutrition 0.000 title description 3
- 239000011782 vitamin Substances 0.000 title description 3
- 150000003722 vitamin derivatives Chemical class 0.000 title description 3
- 239000000203 mixture Substances 0.000 claims abstract description 103
- 206010040844 Skin exfoliation Diseases 0.000 claims abstract description 45
- GFTUVGXUYWIPMI-BHMOCAHYSA-N (2r,3s,4r,5r,6r)-2-(hydroxymethyl)-6-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methyl]oxane-3,4,5-triol Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)C[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GFTUVGXUYWIPMI-BHMOCAHYSA-N 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000002537 cosmetic Substances 0.000 claims abstract description 12
- 230000002708 enhancing effect Effects 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims description 31
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 claims description 21
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 14
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 230000000699 topical effect Effects 0.000 claims description 7
- BYRJNWIHXADTSH-UHFFFAOYSA-N C(CCCCCCCCCCC)C(C(=O)O)CNCCC(=O)O Chemical compound C(CCCCCCCCCCC)C(C(=O)O)CNCCC(=O)O BYRJNWIHXADTSH-UHFFFAOYSA-N 0.000 claims description 4
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 claims description 4
- 239000008406 cosmetic ingredient Substances 0.000 claims description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 3
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical group NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 3
- 229940032094 squalane Drugs 0.000 claims description 3
- 229940031439 squalene Drugs 0.000 claims description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 3
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 claims description 3
- 229960000984 tocofersolan Drugs 0.000 claims description 3
- BWSBEWKXOZREHV-PMSYUDCUSA-N (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]oxane-3,4,5-triol Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BWSBEWKXOZREHV-PMSYUDCUSA-N 0.000 claims description 2
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 229940113116 polyethylene glycol 1000 Drugs 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 2
- POYIQRAKQJCAJV-TXSQEWSBSA-L disodium;3-[2-carboxylatoethyl(dodecyl)amino]propanoate;[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCN(CCC([O-])=O)CCC([O-])=O.OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C POYIQRAKQJCAJV-TXSQEWSBSA-L 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 210000003491 skin Anatomy 0.000 description 47
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 35
- 238000004299 exfoliation Methods 0.000 description 23
- 150000007513 acids Chemical class 0.000 description 19
- 229930003427 Vitamin E Natural products 0.000 description 17
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 17
- 229940046009 vitamin E Drugs 0.000 description 17
- 239000011709 vitamin E Substances 0.000 description 17
- 235000019165 vitamin E Nutrition 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 16
- 206010040880 Skin irritation Diseases 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 230000036556 skin irritation Effects 0.000 description 10
- 231100000475 skin irritation Toxicity 0.000 description 10
- 230000007794 irritation Effects 0.000 description 9
- 230000002378 acidificating effect Effects 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 5
- -1 Tocopheryl Phosphates Chemical class 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 210000000736 corneocyte Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000036548 skin texture Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 241000123069 Ocyurus chrysurus Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000002973 irritant agent Substances 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229960003339 sodium phosphate Drugs 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 235000011008 sodium phosphates Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000025470 Clusia rosea Species 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 240000003890 Commiphora wightii Species 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- OTKJDMGTUTTYMP-UHFFFAOYSA-N dihydrosphingosine Natural products CCCCCCCCCCCCCCCC(O)C(N)CO OTKJDMGTUTTYMP-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003038 phytosphingosines Chemical class 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- OTKJDMGTUTTYMP-ZWKOTPCHSA-N sphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ZWKOTPCHSA-N 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Definitions
- Human skin may be classified into two major parts: the outer layer
- the dermis contains, among other things, blood vessels, nerves, collagen, elastin, and fibroblast cells, which
- the epidermis may be considered to consist of two major zones, an inner or malpighian layer, and an outer or homy layer.
- a living tissue may be further divided into basal, spinous, and granular
- the outer horny layer a dead tissue, is also referred to as stratum
- corneocytes dead cells in the stratum corneum. This process of forming corneocytes is called keratinization.
- the stratum corneum consists of approximately 14 layers of dead cells and is the skin tissue that one feels when
- compositions that protects the living portion of the skin from damage.
- a composition is applied that increases the natural exfoliation rate (cell renewal rate) of the skin, thus increasing the rate at which the outer layers of dead cells (the stratum corneum)
- One conventional method of protecting the living skin cells from oxidative damage is by applying a composition containing ⁇ -Tocopherol
- Vitamin E is oil-soluble and can improve the appearance of the skin through
- Nicotinate, and Tocopherol can also serve to protect living skin cells from oxidative attack.
- Naturally occurring Vitamin E and its oil-soluble derivatives are believed to improve the appearance of skin by reducing oxidative
- VEP DL- ⁇ -Tocopheryl Phosphate
- the derivative may be prepared by reacting Vitamin E with sodium phosphate.
- the '867 patent discloses how VEP can improve the health of animals when administered internally.
- WO 93/15731 discloses how internally administering phosphate derivitized Vitamin E to mice can prevent liver damage. Unlike prior oil-soluble Vitamin E
- VEP is soluble in water.
- Exfoliating acids are known to increase the rate of natural exfoliation. Exfoliating acids include glycolic acid, lactic acid, citric acid, malic acid, tartaric acid, salicylic acid, acetic acid, pyruvic
- hydroxycarboxylic acids including hydroxycarboxylic acids, is that they are most effective at low pH, about
- acidic exfoliating agents are believed to deprotonate at a pH of about 3.8, thus losing their beneficial activity at higher pH due to a lack of bioavailability.
- composition be limited by the exfoliation ability of the acid, but by how often the composition can be applied to the skin without undue irritation.
- exfoliating acids which include hydroxycarboxylic acids, demonstrate a significant stimulation of cell renewal coupled with an undesirable level of skin irritation.
- exfoliating acids which include hydroxycarboxylic acids
- pH of the acidic composition is increased to approach neutral (7.0), cell renewal,
- exfoliation without the skin irritation associated with exfoliating acids. It would be most desirable to provide for enhanced skin exfoliation at a pH more closely approaching neutral to reduce skin irritation.
- the present compositions provide enhanced skin exfoliation at a higher pH and with lower irritation than conventional exfoliating acids, thus overcoming a significant disadvantage of acidic exfoliants.
- the present invention provides a cosmetic or dermopharmaceutical composition for topical use comprising a water-soluble
- Vitamin E derivative and a carrier that includes water.
- the water-soluble Vitamin E derivative is preferably a water-soluble salt of Vitamin E and is in the water
- a water-soluble Vitamin E derivative is present in the composition in an amount effective to increase the rate of natural skin
- the water-soluble Vitamin E derivative enhances the rate of
- compositions including a water-soluble Vitamin E derivative present in a therapeutically effective amount in a topically acceptable carrier for application to human skin to increase the natural rate of skin exfoliation.
- the composition contains from about 0.05% to about 30% of a water-soluble Vitamin
- E derivative and has a pH in the range from about 4.5 to 9.
- Another aspect of the present invention includes a method of increasing the rate of skin exfoliation comprising topically applying a cosmetic composition containing an amount of a water-soluble Vitamin E derivative effective to enhance the rate of skin cell exfoliation beyond the naturally occurring rate of skin cell exfoliation.
- the method includes topically applying to the skin a composition comprising a water-soluble Vitamin E derivative in an amount and for a period of time sufficient to increase the rate of
- the present invention relates to compositions that enhance the rate
- compositions are believed to act by increasing the exfoliation or "release" of dead cells, not by repairing or protecting living skin cells from damage, including oxidative damage from radicals and peroxides.
- present compositions increase the rate at which dead keratinizing cells are
- the visible layer of the skin may be
- the present invention relates to a composition containing a skin benefiting agent that includes a water-soluble Vitamin E derivative that stimulates cell renewal, but does not unduly irritate at the desired
- the present invention includes a composition including sodium phosphate derivatized Vitamin E (VEP).
- VEP sodium phosphate derivatized Vitamin E
- present invention also relates to a method of increasing the rate of skin-cell
- composition comprises an effective amount of a water-soluble Vitamin E derivative and a
- a composition acceptable for topical application to the skin comprises a water-
- the water-soluble Vitamin E salts useful in the present invention include all enantiomers whether singly or in combination.
- preferable salts include phosphates and sulfates, with phosphate salts being presently preferred.
- the cation portion of the salt includes, but is not
- alkali and alkaline earth metals such as sodium, potassium, calcium, and magnesium.
- the cations can be used alone or in a mixture of two or more.
- Sodium is a preferred cation for the salt.
- Suitable water-soluble Vitamin E derivatives may include, for example,
- the Disodium Lauriminodipropionate Tocopheryl Phosphates may be thought of as phosphate salts of Vitamin E and its derivatives having beta-alanine functionality.
- Preferred water-soluble Vitamin E derivatives include Sodium Vitamin E Phosphate (VEP), Lauryl Imino Dipropionic Acid Tocopheryl Phosphate, and Disodium Lauriminodipropionate Tocopheryl Phosphates.
- VEP Sodium Vitamin E Phosphate
- Lauryl Imino Dipropionic Acid Tocopheryl Phosphate Lauryl Imino Dipropionic Acid Tocopheryl Phosphate
- Disodium Lauriminodipropionate Tocopheryl Phosphates Disodium Lauriminodipropionate Tocopheryl Phosphates.
- compositions according to the present invention at least one of the aforementioned water-soluble Vitamin E salts may be mixed with
- a pharmaceutically or cosmetically acceptable carrier that includes water.
- a pharmaceutically or cosmetically acceptable carrier that includes water.
- from about 0.05% to about 30% of the composition is the water- soluble Vitamin E derivative, more preferably from about 0.1% to about 15%.
- compositions including from about 0.4% to about 5% of the water- soluble Vitamin E derivative is especially preferred. Unless stated otherwise, all
- the carrier is capable of assisting in maintaining the desired pH of the composition.
- the pH values for the compositions of the present invention are from about 4.5 to about 9, preferably from 4.8 to 8.2, and
- a pH of 5 is an order of magnitude less acidic than a pH of 4.
- the water-soluble Vitamin E derivative is not combined to form a composition containing exfoliating acids, squalene, or squalane.
- squalane is a saturated hydrocarbon formed by reduction of squalene
- the composition does not include an exfoliating acid at a concentration sufficient to provide an increase in exfoliation rate. In another aspect, the composition does not include an exfoliating acid at a concentration sufficient to provide an increase in exfoliation rate. In another aspect, the composition does
- composition does not contain greater than 2% of an exfoliating acid.
- composition does not contain an exfoliating acid having a bioavailability of 4% or
- compositions of the present invention may be formulated as a
- the water-based composition contains oil, the water-soluble Vitamin E salt is substantially in
- the cosmetically acceptable carrier includes water and preferably
- the composition acts as a dilutant, dispersant, or carrier for other cosmetic ingredients present in the composition, so as to facilitate their distribution when the composition is applied to the skin.
- the composition includes from 5 to 98% water and more preferably from 80 to 98% water.
- compositions of the present invention may also contain various conventional cosmetic ingredients, so long as they do not detrimentally affect the desired enhancement of skin exfoliation or composition pH.
- Suitable cosmetic ingredients so long as they do not detrimentally affect the desired enhancement of skin exfoliation or composition pH.
- ingredients can include liquid or solid emollients, organic or inorganic
- sunscreens preservatives, buffers, solvents, humectants, viscosity modifiers, alcohols, fats, oils, surfactants, fatty acids, silicone oils, moisturizers, emulsifiers,
- compositions may also include propellants such as propane, isobutane, dimethyl ether, carbon dioxide,
- emollients refer to materials used for the prevention or relief of dryness, as well as for the protection of the skin. Wide
- compositions can optionally include inorganic and organic sunscreens as cosmetic ingredients that provide protection from the harmful
- compositions include from 0.1 to 10% and more preferably from 1 to 5% of an organic sunscreen.
- organic sunscreens include those set out in
- compositions may also contain an inorganic compound
- sunscreen which includes, but is not limited to titanium dioxide; zinc oxide, having an average particle size of from 1 to 300 nm; iron oxide, having an
- silica such as fumed silica, having an average particle size of from 1 to 100 nm.
- titanium dioxide that can be incorporated in the composition is from 1 to 25%, preferably from 2 to 10%, and ideally from 3 to 7%.
- anti-irritant agents into the claimed compositions.
- the natural anti-inflammatory and/or anti-irritant agents are preferred.
- licorice and its extracts dipotassium glycyrrhizinate, oat and oat extracts, candelilla wax, alpha bisabolol,
- Additional skin benefit agents such as ceramides, glycoceramides, pseudoceramides, sphingolipids such as sphingomyelins, cerebrosides,
- sulphatides and ganglioside, sphingosines, dihydrosphingosine, phytosphingosines, and phospholipids, may also be incorporated into the claimed compositions, either separately or in mixtures.
- Fatty acids may also be
- glycoceramides include those described in U.S. Patent No. 5,589,178,
- the pseudoceramides include those described in U.S. Patent No. 5,198,210; 5,206,020; and 5,415,855.
- the rate of natural skin exfoliation may be increased by topical application to the skin of the claimed compositions.
- the present invention encompasses a
- composition comprising a water-soluble Vitamin E derivative (salt) in an amount and for a period of time sufficient to increase the
- Vitamin E salt is N-(2-a rate of natural skin exfoliation.
- Vitamin E salt is N-(2-a rate of natural skin exfoliation.
- the topical composition is applied on at least a daily
- compositions of the present invention may be applied on a more regular basis with substantially reduced irritation to the skin. While not wishing to be bound by any particular theory, the
- compositions By applying the present compositions on a routine basis to the skin, within a few days, a user may notice improved skin texture and smoothness with reduced
- Table 3 sets forth a comparative study between the cell-renewal rates of a water-soluble Vitamin E derivative (VEP, a sodium-phosphate salt)
- VEP water-soluble Vitamin E derivative
- beneficial cell-renewal rates are achieved at surprisingly low sting
- exfoliating acids such as lactic acid, salicylic acid, and the alpha and beta hydroxycarboxylic acids, are commonly thought of
- compositions of the present invention can provide beneficial exfoliation rates above pH 4.5.
- desirable cell renewal rates are seen at pH of about 5.6 and higher, and at pH values of about 7.2 and higher. This is quite surprising because conventional exfoliating
- compositions of the present invention provide beneficial exfoliation above pH 4.5
- VEP is somewhat slower than Lactic Acid at cell-renewal, it is at least 4.5 times less irritating to the skin.
- pH 7.21 for example
- composition is about one-twentieth as irritating to the skin.
- present composition is about one-twentieth as irritating to the skin.
- the claimed compositions can reduce consumer perceived skin irritation (Sting %) by at least 25% and more preferably by at least 50% in relation to results
- compositions can be used more often and more regularly than conventional acid- based exfoliating compositions to improve the skin.
- conventional acid- based exfoliating compositions to improve the skin.
- compositions can provide an overall increase in the rate of skin cell- renewal when compared with compositions containing exfoliating acids because
- the claimed compositions can be applied more frequently with reduced irritation.
- Table 5 presents several examples of proposed emulsion, cream,
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003296454A AU2003296454A1 (en) | 2002-12-19 | 2003-12-10 | Increasing skin cell renewal with water-soluble vitamin e |
EP03814700A EP1583514A2 (en) | 2002-12-19 | 2003-12-10 | Increasing skin cell renewal with water-soluble vitamin e |
JP2004565335A JP2006514047A (en) | 2002-12-19 | 2003-12-10 | Promotion of skin cell regeneration by water-soluble vitamin E |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/325,326 | 2002-12-19 | ||
US10/325,326 US6645514B1 (en) | 2002-12-19 | 2002-12-19 | Increasing skin cell renewal with water-soluble Vitamin E |
US10/684,140 US20040131569A1 (en) | 2002-12-19 | 2003-10-10 | Increasing skin cell renewal with water-soluble vitamin E |
US10/684,140 | 2003-10-10 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004060341A2 true WO2004060341A2 (en) | 2004-07-22 |
WO2004060341A3 WO2004060341A3 (en) | 2005-03-03 |
WO2004060341B1 WO2004060341B1 (en) | 2005-04-14 |
Family
ID=32716851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/039275 WO2004060341A2 (en) | 2002-12-19 | 2003-12-10 | Increasing skin cell renewal with water-soluble vitamin e |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1583514A2 (en) |
JP (1) | JP2006514047A (en) |
KR (1) | KR20050089045A (en) |
AU (1) | AU2003296454A1 (en) |
WO (1) | WO2004060341A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005053785A (en) * | 2003-05-20 | 2005-03-03 | Nippon Menaade Keshohin Kk | External preparation |
JP2014084308A (en) * | 2012-10-25 | 2014-05-12 | Fancl Corp | Liquid crystal composition |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2657526B1 (en) * | 1990-01-31 | 1994-10-28 | Lvmh Rech | USE OF AN ALPHA-TOCOPHEROL PHOSPHATE, OR ONE OF ITS DERIVATIVES, FOR THE PREPARATION OF COSMETIC, DERMATOLOGICAL, OR PHARMACEUTICAL COMPOSITIONS; COMPOSITIONS THUS OBTAINED. |
WO1993015731A1 (en) * | 1992-02-14 | 1993-08-19 | Robert Lamb | Phosphate derivatives of vitamin e to protect cells from effects of aging and injury |
EP0716589A4 (en) * | 1993-07-23 | 1997-06-11 | Morris Herstein | Cosmetic, skin-renewal stimulating composition with long-term irritation control |
JP4115524B2 (en) * | 1995-10-17 | 2008-07-09 | 昭和電工株式会社 | High-purity tocopherol phosphates, production method thereof, analysis method thereof and cosmetics |
JP3950216B2 (en) * | 1997-12-26 | 2007-07-25 | 日本メナード化粧品株式会社 | Topical skin preparation |
FR2775441B1 (en) * | 1998-02-27 | 2000-04-28 | Serobiologiques Lab Sa | MATRIX FOR THE PREPARATION OF MICROPARTICLES OR NANOPARTICLES, PROCESS FOR PRODUCING SUCH PARTICLES AND PARTICLES OBTAINED |
ID26725A (en) * | 1998-05-15 | 2001-02-01 | Showa Denko Kk | SUBSTANCE TO PREVENT AND TREAT SKIN DISEASE |
FI110157B (en) * | 2000-10-12 | 2002-12-13 | Duraban Oy | Antimicrobial polyalphaolefin composition and its use, process for the preparation of styrene-butadiene block copolymers containing thermoplastic elastomers and their use |
ES2334207T3 (en) * | 2000-11-14 | 2010-03-08 | Vital Health Sciences Pty Ltd. | COMPOSITIONS THAT INCLUDE TOCOFEROL PHOSPHATE DERIVATIVES COMPLEXES. |
JP4620326B2 (en) * | 2000-11-14 | 2011-01-26 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | Formulation containing a phosphate derivative of an electron transfer agent |
CN1652746A (en) * | 2002-05-09 | 2005-08-10 | 昭和电工株式会社 | Skin whitening external preparation |
-
2003
- 2003-12-10 EP EP03814700A patent/EP1583514A2/en not_active Withdrawn
- 2003-12-10 JP JP2004565335A patent/JP2006514047A/en active Pending
- 2003-12-10 WO PCT/US2003/039275 patent/WO2004060341A2/en not_active Application Discontinuation
- 2003-12-10 AU AU2003296454A patent/AU2003296454A1/en not_active Abandoned
- 2003-12-10 KR KR1020057010882A patent/KR20050089045A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2006514047A (en) | 2006-04-27 |
WO2004060341B1 (en) | 2005-04-14 |
AU2003296454A1 (en) | 2004-07-29 |
WO2004060341A3 (en) | 2005-03-03 |
EP1583514A2 (en) | 2005-10-12 |
KR20050089045A (en) | 2005-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6645514B1 (en) | Increasing skin cell renewal with water-soluble Vitamin E | |
EP0855904B1 (en) | Barrier disruption treatments for structurally deteriorated skin | |
US7431940B2 (en) | Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods | |
JP2000327558A (en) | Method for increasing cell rejuvenscence speed | |
JPH1072334A (en) | Oxa-acid for care of skin state and related compound | |
US5043356A (en) | Composition and method for rejuvenating skin using vitamin A propionate | |
WO2017100873A1 (en) | Cosmetic composition and use thereof | |
KR102463133B1 (en) | Cosmetic Composition Containing High-Content of Urea | |
US3867522A (en) | Acne composition | |
JP2000273033A (en) | Gel comprising natural material | |
US20030095991A1 (en) | Treatment for skin | |
BR112013024572B1 (en) | Cosmetic process and cosmetic use of at least one compound of formula (I) | |
JP2019523300A (en) | Skin care products and their use | |
EP1420743B1 (en) | Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function | |
US6984391B2 (en) | Compositions and methods for delivery of skin cosmeceuticals | |
WO2006122668A1 (en) | Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine | |
WO2004060341A2 (en) | Increasing skin cell renewal with water-soluble vitamin e | |
US20050281853A1 (en) | Skin compatible cosmetic compositions and delivery methods therefor | |
CA2234968A1 (en) | Topically applied, structural cellulite treatments | |
JP2006298796A (en) | External preparation for improving fine wrinkle | |
WO2024056566A1 (en) | Use of thioethylamine composition for skin rejuvenation and improved synergistic effect when combined with an organic acid and/or azabenzene-4-carboxamide | |
US20050152862A1 (en) | Cosmetic peeling method | |
US20050255132A1 (en) | Softening cream | |
US20130149362A1 (en) | Treatment product and method | |
WO1997018804A1 (en) | Rejuvenating the skin using a combination of vitamin a and alphahydroxy acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
B | Later publication of amended claims |
Effective date: 20041019 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057010882 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004565335 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003814700 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038A98011 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057010882 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003814700 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003814700 Country of ref document: EP |